Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bertino J. R. Toward improved selectivity in cancer chemotherapy: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 1979 Feb;39(2 Pt 1):293–304. [PubMed] [Google Scholar]
- Bhuyan B. K., Fraser T. J., Gray L. G., Kuentzel S. L., Neil G. L. Cell-kill kinetics of several S-phase-specific drugs. Cancer Res. 1973 Apr;33(4):888–894. [PubMed] [Google Scholar]
- Boehm T. L., Drahovsky D. Elevated level of enzymatic DNA methylation in cells treated with 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1982 Apr;42(4):1537–1540. [PubMed] [Google Scholar]
- Chabner B. A., Myers C. E., Coleman C. N., Johns D. G. The clinical pharmacology of antineoplastic agents (first of two parts). N Engl J Med. 1975 May 22;292(21):1107–1113. doi: 10.1056/NEJM197505222922107. [DOI] [PubMed] [Google Scholar]
- Crissman H. A., Tobey R. A. Cell-cycle analysis in 20 minutes. Science. 1974 Jun 21;184(4143):1297–1298. doi: 10.1126/science.184.4143.1297. [DOI] [PubMed] [Google Scholar]
- Gasson J. C., Ryden T., Bourgeois S. Role of de novo DNA methylation in the glucocorticoid resistance of a T-lymphoid cell line. Nature. 1983 Apr 14;302(5909):621–623. doi: 10.1038/302621a0. [DOI] [PubMed] [Google Scholar]
- Gledhill R. M., Edwards A. J., Norman M. R. Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside. Br J Cancer. 1983 May;47(5):649–657. doi: 10.1038/bjc.1983.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gledhill R. M., Norman M. R. Antagonism of drugs used in leukaemia therapy to the killing of human lymphoblastoid cells by steroid. Br J Cancer. 1981 Sep;44(3):467–471. doi: 10.1038/bjc.1981.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krakoff I. H., Brown N. C., Reichard P. Inhibition of ribonucleoside diphosphate reductase by hydroxyurea. Cancer Res. 1968 Aug;28(8):1559–1565. [PubMed] [Google Scholar]
- Major P. P., Sargent L., Egan E. M., Kufe D. W. Correlation of thymidine-enhanced incorporation of ara-C in deoxyribonucleic acid with increased cell kill. Biochem Pharmacol. 1981 Aug 15;30(16):2221–2224. doi: 10.1016/0006-2952(81)90091-5. [DOI] [PubMed] [Google Scholar]
- Momparler R. L. Kinetic and template studies with 1- -D-arabinofuranosylcytosine 5'-triphosphate and mammalian deoxyribonucleic acid polymerase. Mol Pharmacol. 1972 May;8(3):362–370. [PubMed] [Google Scholar]
- Nelson J. A., Carpenter J. W., Rose L. M., Adamson D. J. Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine. Cancer Res. 1975 Oct;35(10):2872–2878. [PubMed] [Google Scholar]
- Norman M. R., Harmon J. M., Thompson E. B. Use of a human lymphoid cell line to evaluate interactions between prednisolone and other chemotherapeutic agents. Cancer Res. 1978 Nov;38(11 Pt 2):4273–4278. [PubMed] [Google Scholar]
- Shackney S. E., Ford S. S., Occhipinti S. J., Ritch P. S., Riccardi R., Erickson B. W., Jr Schedule optimization of hydroxyurea and 1-beta-D-arabinofuranosylcytosine in sarcoma 180 in vitro. Cancer Res. 1982 Nov;42(11):4339–4347. [PubMed] [Google Scholar]
- TROWELL O. A. The culture of lymph nodes in synthetic media. Exp Cell Res. 1955 Oct;9(2):258–276. doi: 10.1016/0014-4827(55)90099-9. [DOI] [PubMed] [Google Scholar]
- Tidd D. M., Paterson A. R. Distinction between inhibition of purine nucleotide synthesis and the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res. 1974 Apr;34(4):733–737. [PubMed] [Google Scholar]
- Tobey R. A., Crissman H. A. Use of flow microfluorometry in detailed analysis of effects of chemical agents on cell cycle progression. Cancer Res. 1972 Dec;32(12):2726–2732. [PubMed] [Google Scholar]
- Walters R. A., Tobey R. A., Hildebrand C. E. Hydroxyurea does not prevent synchronized G1 chinese hamster cells from entering the DNA synthetic period. Biochem Biophys Res Commun. 1976 Mar 8;69(1):212–217. doi: 10.1016/s0006-291x(76)80294-x. [DOI] [PubMed] [Google Scholar]
